RARITAN, N.J., June 19, 2013 /PRNewswire/ — Janssen Research & Development, LLC (Janssen) today announced The New England Journal of Medicine (NEJM) has published data online about the investigational oral Bruton’s Tyrosine Kinase (BTK) inhibitor ibrutinib as a…

Load More Related Articles
Load More In Entertainment